FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Look at FDA Role in Drug Competition: Report

[ Price : $8.95]

A Matrix Global Advisors report says more attention should be paid to the ways in which FDA helps and hurts drug price competition...

New Requirements for Info on ClinicalTrials.gov

[ Price : $8.95]

The National Institutes of Health proposes new rules on registration and summary results information from some clinical trials for...

FDA Approves Safety Labeling Changes for 37 Drugs

[ Price : $8.95]

FDA approves safety labeling changes for 37 drugs including a Boxed Warning about suicidality for Lillys Cymbalta.

Agency Pushes Back ANDA Labeling Final Rule

[ Price : $8.95]

FDA delays finalizing a proposed rule that would require generic drug makers to use the same process as brand drug manufacturers t...

Comments Sought on ANDA Priority Reviews for First Generics

[ Price : $8.95]

FDA opens a public docket requesting comments on proposed criteria for first generic ANDA submissions in order for the agency to s...

FDA Clears Aurora Spines Spinal Implant

[ Price : $8.95]

FDA clears an Aurora Spine Corp. 510(k) for its Zip 51, an interspinous fixation implant for spinal fusion procedures.

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Eastern Pharmacy, Dr. Benedict Schue-Schie Liao, MKL Diagnostics, Wells Pharmacy...

Ranbaxy Fights Loss of Tentative Approvals

[ Price : $8.95]

Attorney Kurt Karst says Ranbaxy has told a DC federal court that FDA does not have the right to strip the company of two tentativ...

Hamburg Building Stronger Ties on Trip to China

[ Price : $8.95]

FDA commissioner Margaret Hamburg meets with Chinese officials this week in China to discuss additional ways in which the two nati...

Guidance on Rare Pediatric Disease Priority Review Vouchers

[ Price : $8.95]

FDA releases a draft guidance on Rare Pediatric Disease Priority Review Vouchers that provides information on implementing Section...